Pediatrix Medical

Forecast & Rating7 analysts currently cover Pediatrix Medical, with about 28.6% giving a positive rating — meaning they expect the stock to rise. The average price target is $24.50, about 7.5% downside from the current price of $26.48. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 57.8% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Pediatrix Medical's outlook. Data as of Jul 25, 2026; for reference only and not investment advice.